| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 6, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 60,743 | $51.75 | $3,143,195.16 | -23.1% | +11.9% | -12.7% | |
| Sep 6, 2023 | DERM Journey Medical Corp | Rosenwald Lindsay A Md64 | Director | Buy | 100,000 | $2.23 | $223,000.00 | +702.0% | +128.7% | +87.3% | |
| Sep 6, 2023 | BHC Bausch Health Companies Inc. | Carson Seana60 | EVP, General Counsel | Sell | 6,685 | $8.28 | $55,351.80 | -1.7% | -14.7% | -26.0% | |
| Sep 6, 2023 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 27,399 | $6.85 | $187,604.61 | -2.2% | +27.9% | +108.8% | |
| Sep 5, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 100,000 | $2.19 | $219,320.00 | +0.1% | - | - | |
| Sep 5, 2023 | VRNO Verano Holdings Corp. | Nunez Cristina Maria | Director | Sell | 16,667 | $2.75 | $45,834.25 | -37.0% | - | - | |
| Sep 5, 2023 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 200,000 | $0.91 | $182,070.00 | -2.5% | - | - | |
| Sep 5, 2023 | KNSA Kiniksa Pharmaceuticals International, Plc | Paolini John F.51 | Chief Medical Officer | Sell | 400 | $17.53 | $7,012.00 | -0.9% | +0.9% | +52.3% | |
| Sep 1, 2023 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 824 | $110.93 | $91,406.32 | -4.6% | +5.4% | +14.9% | |
| Sep 1, 2023 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 923 | $192.97 | $178,111.31 | -3.5% | -8.2% | -4.7% | |
| Sep 1, 2023 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 20,000 | $14.48 | $289,600.00 | -86.3% | -5.8% | -22.8% | |
| Sep 1, 2023 | CGC Canopy Growth Corp | Schmeling Judy56 | Director | Sell | 18,703 | $0.71 | $13,279.13 | -4.1% | +1.8% | -5.3% | |
| Sep 1, 2023 | ANIP Ani Pharmaceuticals Inc | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $64.70 | $1,294,000.00 | -6.0% | -22.9% | -1.3% | |
| Sep 1, 2023 | CGC Canopy Growth Corp | Lazzarato David Angelo75 | Director | Sell | 38,963 | $0.71 | $27,663.73 | -13.7% | +1.8% | -5.3% | |
| Sep 1, 2023 | CBSTF Cannabist Co Holdings Inc. | Hart David James | President &COO | Sell | 60,000 | $0.81 | $48,744.00 | -5.2% | - | - | |
| Sep 1, 2023 | CGC Canopy Growth Corp | Yanofsky Theresa75 | Director | Sell | 38,803 | $0.71 | $27,550.13 | -13.4% | +1.8% | -5.3% | |
| Sep 1, 2023 | NBIX Neurocrine Biosciences Inc | Lyons Gary A54 | Director | Sell | 5,000 | $110.06 | $550,315.50 | -2.4% | +5.4% | +14.9% | |
| Sep 1, 2023 | CBSTF Cannabist Co Holdings Inc. | Channon Jesse | Chief Commercial Officer | Sell | 100,000 | $0.81 | $81,080.00 | -19.1% | - | - | |
| Aug 31, 2023 | LQDA Liquidia Corp | Moomaw Scott | Chief Commercial Officer | Sell | 537 | $6.88 | $3,694.56 | -0.5% | +3.9% | +38.4% | |
| Aug 31, 2023 | LQDA Liquidia Corp | Lippe Robert A54 | Chief Operations Officer | Sell | 505 | $6.88 | $3,474.40 | -0.3% | +3.9% | +38.4% | |
| Aug 31, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 46,541 | $554.81 | $25,821,606.58 | - | +6.8% | +73.2% | |
| Aug 31, 2023 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 445 | $6.88 | $3,061.60 | -0.8% | +3.9% | +38.4% | |
| Aug 31, 2023 | CBSTF Cannabist Co Holdings Inc. | Olson Bryan | Chief People/ Admin Officer | Sell | 98,899 | $0.65 | $64,345.05 | -9.5% | - | - | |
| Aug 30, 2023 | SUPN Supernus Pharmaceuticals, Inc. | Martin Tami Tillotson54 | Sr. V.p., Regulatory Affairs | Sell | 8,100 | $32.00 | $259,200.00 | -8.7% | -15.6% | +9.5% | |
| Aug 30, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 6,181 | $555.32 | $3,432,417.36 | - | +8.0% | +71.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.